Browsing byAuthorKim, Ha Rin

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 3 of 3

Issue DateTitleAuthor(s)
2021-10Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancerLee, Na Kyeong; Choi, Jeong Uk; Kim, Ha Rin; Chung, Seung Woo; Ko, Yoon Gun; Cho, Young Seok; Park, Seong Jin; Lee, Eun Jung; Kim, Sang Yoon; Kim, In-San; Byun, Youngro
2018-07Self-Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase-Cleavable LinkerChung, Seung Woo; Choi, Jeong Uk; Cho, Young Seok; Kim, Ha Rin; Won, Tae Hyung; Dimitrion, Peter; Jeon, Ok-Cheol; Kim, Seong Who; Kim, In-San; Kim, Sang Yoon; Byun, Youngro
2019-02-28The novel strategy for concurrent chemoradiotherapy by conjugating the apoptotic cell-binding moiety to caspase-3 activated doxorubicin prodrugCho, Young Seok; Chung, Seung Woo; Kim, Ha Rin; Won, Tae Hyung; Choi, Jeong Uk; Kim, In-San; Kim, Sang Yoon; Byun, Youngro

BROWSE